DEVELOPMENT OF THE AFFINE MOLECULE TO CIS PROTEIN BY METHODS OF STRUCTUREBASED DRUG DESIGNDEVELOPMENT OF THE AFFINE MOLECULE TO CIS
PROTEIN BY METHODS OF STRUCTUREBASED
DRUG DESIGN
Statins: Unexpected help in COVID-19 on an unprecedented scale. Unfortunately, the process of creating effective antiviral
drugs and vaccines is being
Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin of the mature FimH. The R66 mutation induced an unusually strong 1M-
binding phenotype and a 20-fold advantage
Defining the Specificity of Carbohydrate-Protein Interactions by Quantifying Functional Group Contributions, disruption of which has been implicated in many different diseases. The capability of glycan-
binding proteins